Insilico

GNQ Insilico plans to accelerate the adoption of precision medicine and clinical AI in drug development and patient care

vm_adminApril 15, 2026

By Business Wire Publication Date: 2026-04-15 21:25:00 The new service offering combines GNQ Insilico’s Causal AI Drug Assessment, Drug Simulation…

AI News

First AI-Generated Drugs May Reach Market by 2030: Insilico CEO

vm_adminMay 22, 2025

The first drugs conceived entirely by artificial intelligence will likely be commercially available around the end of the decade, according…

AI News

AI Drug Startup Insilico Weighs Hong Kong IPO After New Funding – Bloomberg

vm_adminMarch 12, 2025

AI Drug Startup Insilico Weighs Hong Kong IPO After New Funding Bloomberg Article Source https://www.bloomberg.com/news/articles/2025-03-12/ai-drug-startup-insilico-weighs-hong-kong-ipo-after-new-funding